MAPT and Alzheimer disease: However, “middle-aged” normal subjects with chronic insomnia or high insomnia scores had greater CSF levels only of Aβ1-42, but not of Aβ1-40, t-tau, or p-tau [53,54]—this suggests that Aβ1-42 may be the earliest AD marker to be affected by insomnia.